{
    "type": "VariantTherapeuticResponseProposition",
    "predicate": "sensitivity",
    "description": "Treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse",
    "geneContextQualifier": "--",
    "objectTherapeutic": "Tisagenlecleucel [Kymriah]"
}